OTC Monograph Drug User Fee Program (OMUFA): Understanding FY 2025 User Fees and Registration – 05/20/2025

Head lice affect millions of children every year. Although head lice are a year-round problem, cases usually peak during back-to-school time. FDA-approved treatments for head lice include over-the-counter and prescription drugs.

Endo, Inc. (OTCQX: NDOI) (“Endo”) announced today that one of its operating subsidiaries, Endo USA, Inc., is expanding its previously announced voluntary recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) due to potential product carton strength mislabeling.

Quesito El Establo of Salem, NH is recalling all Spanish Cheese (Quesito Colombiano) manufactured in their facility, due to the presence of rodent, rodent activity, and other insanitary conditions during the manufacturing and storage process.

Unapproved New Drugs/Misbranded Botox

Fiscal Year 2025 Generic Drug Science and Research Initiatives Public Workshop

Aurobindo Pharma USA Inc – 05/15/2024. Country: United States. Record Type: 483